Treatment with mitoTEMPO, a MnSOD mimetic, reduced blood pressure and oxidative stress and improved the reendothelialization capability of endothelial progenitor cells in AngII-induced hypertension mice, providing a potential vascular repair therapeutic target for hypertension [55,56]. The gene discussed is SOD2; the disease is hypertensive disorder.